QURE analyst estimates
uniQure (QURE) analyst ratings, the average price target and its range, and every firm's latest call.
QURE analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 15, 2026 | UBS | uniQure assumed with a Buy at UBS | $48.00 |
| Oct 5, 2026 | Barclays | uniQure downgraded to Equal Weight from Overweight at Barclays | $28.00 |
| Oct 2, 2026 | RBC Capital | uniQure BV (QURE) PT Lowered to $48 at RBC Capital | $48.00 |
| Sep 30, 2026 | Goldman Sachs | uniQure price target lowered to $31 from $46 at Goldman Sachs | $31.00 |
| Sep 29, 2026 | Wells Fargo | uniQure weakness creates attractive opportunity, says Wells Fargo | $75.00 |
| Jul 30, 2026 | Barclays | uniQure price target lowered to $60 from $65 at Barclays | $60.00 |
| Jun 29, 2026 | H.C. Wainwright | uniQure price target raised to $80 from $50 at H.C. Wainwright | $80.00 |
| Jun 25, 2026 | Mizuho Securities | uniQure BV (QURE) PT Raised to $68 at Mizuho | $68.00 |
| Jun 18, 2026 | Goldman Sachs | uniQure price target raised to $46 from $14 at Goldman Sachs | $46.00 |
| Jun 18, 2026 | Leerink Partners | uniQure BV (QURE) PT Raised to $70 at Leerink | $70.00 |
| Jun 18, 2026 | Barclays | uniQure upgraded to Overweight from Equal Weight at Barclays | $65.00 |
| Jun 18, 2026 | RBC Capital | uniQure price target raised to $65 from $35 at RBC Capital | $65.00 |
| Jun 17, 2026 | Cantor Fitzgerald | uniQure upgraded to Overweight at Cantor Fitzgerald after BLA filing news | $61.00 |
| May 6, 2026 | H.C. Wainwright | uniQure price target lowered to $50 from $70 at H.C. Wainwright | $50.00 |
| May 5, 2026 | Stifel Nicolaus | uniQure price target raised to $28 from $14 at Stifel | $28.00 |
- 12 firms rate QURE: 9 buy, 3 hold, 0 sell.
- The average price target is $53.70 from 10 analysts, from $28.00 to $80.00.
Updated 2026-11-02 17:54 UTC